PATENT CLAIM ANALYSIS

Application Number: 16130820
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "021800"]

Abstract:
New polypeptide agonists of AT2R are disclosed, as well as pharmaceutical compositions comprising the agonists, methods of their use in the treatment of diseases, conditions or disorders characterized by insufficient AT2R activity or excessive AT1R activity, and methods of their use as laboratory reagents for research purposes.

Claim (Index 21):
The method of  claim 1  wherein the agonist is administered for conditions characterized by high blood sugar such as diabetes and metabolic syndrome.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15595517', '15648184', '14773041', '13896937', '12046038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7270436011995691
- 35 USC 102 Novelty (BERT): 0.6110685996414087
- Combined Prediction Score: 0.7154461010437532
- Mean Citation Score: 298.427244
- Max Citation Score: 609.76044
- Similarity Product: 439.8425608783508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test